Registry
Module Specifications
Archived Version 2011 - 2012
| |||||||||||||||||||||||||||||||||||||||||
Description To provide a basic understanding of pharmacology and biopharmacology. To investigate certain pharmacological analytical methods To investigate immunological analysis methods and applications | |||||||||||||||||||||||||||||||||||||||||
Learning Outcomes 1. Describe the principles of pharmacodynamics and pharmacokinetics 2. Distinguish between pharmacology and biopharmacology 3. Differentiate between chemical and biochemical drug analysis 4. Illustrate advanced analytical/bioanalytical techniques for pharma/biopharma separations 5. Describe key advanced techniques in immunoanalysis and their applications 6. Discriminate between the correct choices of antibodies for relevant applications 7. Understand the importance of quality control and ethics in the design of assays and therapies based on antibodies 8. Develop new ideas for use of antibodies | |||||||||||||||||||||||||||||||||||||||||
All module information is indicative and subject to change. For further information,students are advised to refer to the University's Marks and Standards and Programme Specific Regulations at: http://www.dcu.ie/registry/examinations/index.shtml |
|||||||||||||||||||||||||||||||||||||||||
Indicative Content and
Learning Activities Indicative Syllabus-Course DescriptionAdministration of drugs & drug delivery systems Drug Metabolism (phase I & phase II inactivation of drugs) Introduction to BioPharmacology CZE Analysis of pharma/biopharma drugs NMR Analysis of biochemical biopharma drugs Mass Spec analysis of drug molecules Production, isolation and characterisation of antibodies Chimaeric, humanised, human and bifunctional antibodies and their uses Genetics of antibody production-Tumour detection, imaging and treatment using immunological approaches Preparation of antibody/enzyme, antibody/drug and carrier-drug conjugated Immunological method development for antigen detection and disease diagnosis-Immunocytochemistry Biosensors Biochips and arrays and their applications-Case studies in immunoanalysis | |||||||||||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||||||||||
Indicative Reading List | |||||||||||||||||||||||||||||||||||||||||
Other Resources None | |||||||||||||||||||||||||||||||||||||||||
Programme or List of Programmes |
AS | BSc in Analytical Science |
SHSA | Study Abroad (Science & Health) |
SHSAO | Study Abroad (Science & Health) |
- See the module specification for BE403 in 2003 - 2004
- See the module specification for BE403 in 2004 - 2005
- See the module specification for BE403 in 2005 - 2006
- See the module specification for BE403 in 2006 - 2007
- See the module specification for BE403 in 2007 - 2008
- See the module specification for BE403 in 2008 - 2009
- See the module specification for BE403 in 2009 - 2010
- See the module specification for BE403 in 2010 - 2011
- See the module specification for BE403 in 2011 - 2012
- See the module specification for BE403 in 2012 - 2013
- See the module specification for BE403 in 2013 - 2014
- See the module specification for BE403 in 2014 - 2015
- See the module specification for BE403 in 2015 - 2016
- See the module specification for BE403 in 2016 - 2017
- See the module specification for BE403 in 2017 - 2018
- See the module specification for BE403 in 2018 - 2019
- See the module specification for BE403 in 2019 - 2020
- See the module specification for BE403 in 2020 - 2021
- See the module specification for BE403 in 2021 - 2022
- See the module specification for BE403 in 2022 - 2023
- See the module specification for BE403 in 2023 - 2024
- See the module specification for the current year